CLRD · Clearday, Inc. - Financials
Annual line items from SEC XBRL filings, sourced from EDGAR's Company Facts API with fallback to the quarterly Financial Statement Data Sets. See issuer overview for Form 4 activity and 10-K signals.
Income Statement
| Line item | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 | Q3 '22 | Q2 '22 | Q1 '22 | Q4 '21 | Q3 '21 | Q2 '21 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $831.9K | $619.0K | $3.21M | - | $3.06M | $3.30M | $3.21M | - | $2.64M | - |
| Cost of Revenue | - | - | - | - | - | - | - | - | - | - |
| Gross Profit | - | - | - | - | - | - | - | - | - | - |
| R&D | - | - | - | - | - | $414.7K | - | - | $812.8K | - |
| SG&A | $565.8K | $944.4K | $880.5K | - | $1.68M | $1.58M | $1.39M | - | $999.1K | $566.0K |
| Total Operating Expenses | $2.62M | $2.03M | $5.02M | - | $6.13M | $7.05M | $6.21M | - | $13.57M | $566.0K |
| D&A | $229.0K | $229.2K | $296.8K | - | $178.7K | $129.7K | $187.2K | - | $129.1K | $0 |
| Operating Income | ($1.78M) | ($1.41M) | ($2.01M) | - | ($3.07M) | ($2.48M) | ($3.00M) | - | ($3.39M) | ($566.0K) |
| Interest Expense | - | - | - | - | $1.03M | $194.6K | $78.8K | - | - | - |
| Income Tax | - | - | - | - | - | - | $0 | - | - | - |
| Net Income | ($4.74M) | ($6.24M) | $109.1K | - | ($226.2K) | ($2.41M) | ($3.97M) | - | ($12.27M) | ($566.0K) |
| EPS - Basic | ($0.16) | ($0.16) | ($0.18) | - | ($0.88) | ($0.12) | ($0.30) | - | - | - |
| EPS - Diluted | ($0.01) | ($0.16) | ($0.30) | - | - | - | - | - | - | - |
Balance Sheet
| Line item | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 | Q3 '22 | Q2 '22 | Q1 '22 | Q4 '21 | Q3 '21 | Q2 '21 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $99.8K | $8.1K | $81.4K | $195.6K | $2.76M | $696.9K | $696.9K | $965.1K | $369.9K | $342.0K |
| Accounts Receivable | - | $381.9K | $58.4K | $47.7K | $74.8K | $118.5K | $44.6K | $50.8K | $38.1K | - |
| Inventory | - | - | - | - | - | - | - | - | - | $68.0K |
| Accounts Payable | $3.45M | $3.64M | $3.60M | $6.32M | $6.25M | $5.53M | $4.30M | $3.39M | $3.55M | $185.0K |
| Current Assets | $477.5K | $542.0K | $264.0K | $466.6K | $315.0K | $3.31M | $3.56M | $3.92M | $1.28M | $758.0K |
| Total Assets | $10.21M | $10.25M | $10.25M | $33.75M | $33.76M | $45.09M | $46.14M | $46.54M | $51.65M | $2.36M |
| Current Liabilities | $39.63M | $35.70M | $32.35M | $39.32M | $31.91M | $32.11M | $26.98M | $23.55M | $23.06M | $200.0K |
| Long-term Debt | $4.54M | $5.62M | $4.62M | $1.39M | $1.09M | $1.93M | $5.56M | $5.57M | $2.62M | $468.0K |
| Total Liabilities | $44.18M | $41.32M | $36.98M | $65.13M | $58.69M | $70.77M | $69.55M | $66.48M | $68.92M | $668.0K |
| Stockholders' Equity | ($63.65M) | ($60.74M) | ($59.79M) | ($63.55M) | ($58.12M) | ($57.20M) | ($53.22M) | ($48.12M) | ($42.68M) | $2.71M |
| Retained Earnings | ($86.22M) | ($83.76M) | ($79.01M) | ($79.67M) | ($67.24M) | ($67.14M) | ($64.81M) | ($65.21M) | ($68.65M) | ($333.06M) |
Cash Flow
| Line item | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 | Q3 '22 | Q2 '22 | Q1 '22 | Q4 '21 | Q3 '21 | Q2 '21 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | ($1.05M) | - | - | - | ($2.12M) | - | - | - |
| Investing Cash Flow | - | - | ($37.4K) | - | - | - | ($506.7K) | - | - | - |
| Financing Cash Flow | - | - | $885.4K | - | - | - | $2.56M | - | - | - |
| CapEx | - | - | $37.4K | - | - | - | $26.7K | - | - | - |
| Free Cash Flow | - | - | ($1.08M) | - | - | - | ($2.15M) | - | - | - |
Ratios
| Metric | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 | Q3 '22 | Q2 '22 | Q1 '22 | Q4 '21 | Q3 '21 | Q2 '21 |
|---|---|---|---|---|---|---|---|---|---|---|
| Profitability | ||||||||||
| Gross margin | - | - | - | - | - | - | - | - | - | - |
| Operating margin | -214.4% | -227.1% | -62.7% | - | -100.4% | -75.2% | -93.6% | - | -128.6% | - |
| EBITDA margin | -186.9% | -190.1% | -53.5% | - | -94.6% | -71.3% | -87.8% | - | -123.7% | - |
| Net margin | -569.3% | -1007.7% | 3.4% | - | -7.4% | -73.0% | -123.7% | - | -465.3% | - |
| Free cash flow margin | - | - | -33.8% | - | - | - | -66.9% | - | - | - |
| FCF / Net income | - | - | -9.94 | - | - | - | 0.54 | - | - | - |
| R&D / Revenue | - | - | - | - | - | 12.6% | - | - | 30.8% | - |
| SG&A / Revenue | 68.0% | 152.6% | 27.4% | - | 54.9% | 48.0% | 43.4% | - | 37.9% | - |
| Effective tax rate | - | - | - | - | - | - | - | - | - | - |
| Return on assets | -46.4% | -60.9% | 1.1% | - | -0.7% | -5.3% | -8.6% | - | -23.8% | -24.0% |
| Return on equity | 7.4% | 10.3% | -0.2% | - | 0.4% | 4.2% | 7.5% | - | 28.8% | -20.9% |
| Return on invested capital | - | - | - | - | - | - | - | - | - | - |
| Liquidity | ||||||||||
| Current ratio | 0.01 | 0.02 | 0.01 | 0.01 | 0.01 | 0.10 | 0.13 | 0.17 | 0.06 | 3.79 |
| Quick ratio | 0.01 | 0.02 | 0.01 | 0.01 | 0.01 | 0.10 | 0.13 | 0.17 | 0.06 | 3.45 |
| Cash ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.09 | 0.02 | 0.03 | 0.04 | 0.02 | 1.71 |
| Leverage | ||||||||||
| Debt / Equity | -0.07 | -0.09 | -0.08 | -0.02 | -0.02 | -0.03 | -0.10 | -0.12 | -0.06 | 0.17 |
| Debt / Assets | 0.45 | 0.55 | 0.45 | 0.04 | 0.03 | 0.04 | 0.12 | 0.12 | 0.05 | 0.20 |
| Debt / EBITDA | - | - | - | - | - | - | - | - | - | - |
| Interest coverage | - | - | - | - | -3.0x | -12.7x | -38.1x | - | - | - |
| Equity multiplier | -0.16 | -0.17 | -0.17 | -0.53 | -0.58 | -0.79 | -0.87 | -0.97 | -1.21 | 0.87 |
| Liabilities / Assets | 4.33 | 4.03 | 3.61 | 1.93 | 1.74 | 1.57 | 1.51 | 1.43 | 1.33 | 0.28 |
| Efficiency | ||||||||||
| Asset turnover | 0.08 | 0.06 | 0.31 | - | 0.09 | 0.07 | 0.07 | - | 0.05 | - |
| Inventory turnover | - | - | - | - | - | - | - | - | - | - |
| Days sales outstanding | - | 225d | 7d | - | 9d | 13d | 5d | - | 5d | - |
| Days inventory outstanding | - | - | - | - | - | - | - | - | - | - |
| Days payable outstanding | - | - | - | - | - | - | - | - | - | - |
| Cash conversion cycle | - | - | - | - | - | - | - | - | - | - |
| Valuation | ||||||||||
| P / E | - | - | - | - | - | - | - | - | - | - |
| P / B | - | - | - | - | - | - | - | - | - | - |
| P / S | 17.0x | 32.9x | 2.4x | - | - | - | - | - | - | - |
| EV / EBITDA | - | - | - | - | - | - | - | - | - | - |
| Growth | ||||||||||
| Revenue growth (YoY) | -72.8% | -81.2% | 0.0% | - | 15.9% | - | - | - | - | - |
| Revenue CAGR (3y) | - | - | - | - | 169.0% | 60.8% | 135.4% | - | 172.7% | - |
| Revenue CAGR (5y) | 45.0% | -4.8% | 67.2% | - | 168.3% | 233.5% | 402.7% | - | 160.5% | - |
| Gross profit growth (YoY) | - | - | - | - | - | - | - | - | - | - |
| Operating income growth (YoY) | 41.9% | 43.3% | 33.0% | - | 9.5% | -338.1% | -428.0% | - | -459.6% | 24.0% |
| Net income growth (YoY) | -1994.1% | -159.3% | - | - | 98.2% | -325.1% | -597.9% | - | -1924.6% | 23.9% |
| EPS growth (YoY) | - | - | - | - | - | - | - | - | - | - |
| EPS CAGR (3y) | - | - | - | - | - | - | - | - | - | - |
| EPS CAGR (5y) | - | - | - | - | - | - | - | - | - | - |
| FCF growth (YoY) | - | - | 49.5% | - | - | - | - | - | - | - |
| FCF CAGR (5y) | - | - | - | - | - | - | - | - | - | - |
| Book value growth (YoY) | -9.5% | -6.2% | -12.4% | -32.1% | -36.2% | - | - | - | - | 23.0% |
Sales by segment
From XBRL dimensional facts in the 10-K period ending 2022-12-31.
Product / service
$12.49M totalResident Fee$12.09M · 96.8%
Adult Day Care$260.3K · 2.1%
Commercial Property Rental Revenue$135.4K · 1.1%
Peer comparison
Same SIC group: Services-Nursing & Personal Care Facilities
Comparing Clearday against the 5 most active filers in the same SIC group.